June 8, 2018 10:29 AM EDT

After snatching up Shire's cancer unit, French pharma giant Servier to expand US presence with Kendall Square innovation office

Brittany Meiling

Servier, the French pharma giant that just acquired Shire’s oncology unit for $2.4 billion, is putting a US innovation outpost in Kendall Square. The new …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

After snatching up Shire's cancer unit, French pharma giant Servier to expand US presence with Kendall Square innovation office

Brittany Meiling

Sign up to read this article for free.

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

'Go ahead and do it': Top RFK Jr. deputy dares drugmakers that might pull manufacturing over new price pressure

The inside story of the six-month sprint to create the first custom CRISPR therapy for one infant’s rare disease

New CBER chief Prasad is readying 'massive framework' around vaccines, Makary says

Eli Lilly turns to South Korean RNA editing biotech for hearing loss in deal worth $1.3B

Bristol Myers CEO says America’s biopharma pole position is not guaranteed

Exclusive: Drug compounder Empower was built on risky shortcuts, ex-employees and inspections allege

Af­ter snatch­ing up Shire's can­cer unit, French phar­ma gi­ant Servi­er to ex­pand US pres­ence with Kendall Square in­no­va­tion of­fice

Sign up to read this article for free.

more like this

Celldex Therapeutics

Hampton, NJ, USA

After snatching up Shire's cancer unit, French pharma giant Servier to expand US presence with Kendall Square innovation office